2020
DOI: 10.3389/fphar.2019.01564
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Prescription-Protein-Small Molecule-Disease Strategy (CPSD), A New Strategy for Chinese Medicine Development: A Case Study in Cardiovascular Diseases

Abstract: Chinese medicine is a national treasure that has been passed down for thousands of years in China. According to the statistics of the World Health Organization, there are currently four billion people in the world who use Chinese medicine to treat diseases, accounting for 80% of the world's total population. However, the obscurity of its theory, its unmanageable quality, its complex compositions, and the unknown effective substances and mechanisms are great obstacles to the internationalization of Chinese medi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 77 publications
(70 reference statements)
0
1
0
Order By: Relevance
“…In contrast, traditional Chinese medicine (TCM) offers cost-effective solutions with fewer disadvantages [ 5 ]. An example of such a treatment is Liu's Zhenggudan Formula (LZF), which includes LZF1 and LZF2.…”
Section: Introductionmentioning
confidence: 99%
“…In contrast, traditional Chinese medicine (TCM) offers cost-effective solutions with fewer disadvantages [ 5 ]. An example of such a treatment is Liu's Zhenggudan Formula (LZF), which includes LZF1 and LZF2.…”
Section: Introductionmentioning
confidence: 99%